Publication Beamlines Strategic Pillar
Canova, H; Fontoura, A; Neuenschwander, R T; Diaz, B; Rodella, C B et al. (2014). Upgrades to the XRD1 beamline optics and endstation at the LNLS. Journal of Physics: Conference Series 493, 012004. 10.1088/1742-6596/493/1/012004.
Dallin , L.O.; Sigrist, M.J.; Summers, T. (2014). Canadian Light Source Update - (Russian). In RuPAC 2006. Joint Accelerator Conferences Website (JACoW). 9783954500383.
Dallin, L.O.; Wurtz, W.A. (2014). Low Emittance Lattice Design for the Canadian Light Source. In Proceedings of IPAC'14. International Particle Accelerator Conference. 9783954501328.
Wurtz, W.A.; Bertwistle, D.; Dallin, L.O.; Sigrist, M.J. (2014). Simulation of a Long-period EPU Operating in Universal Mode at the Canadian Light Source. In Proceedings of IPAC'14. International Particle Accelerator Conference. 9783954501328.
Wurtz, W.A.; Dallin, L.O.; Bertwistle, D.; Sigrist, M.J.; Vogt, J.M. et al. (2014). Preventing Superconducting Wiggler Quench during Beam Loss at the Canadian Light Source. In Proceedings of IPAC'14. International Particle Accelerator Conference. 9783954501328.
Wurtz, W.A. (2014). Photodisintegration of lithium isotopes. Canada, SK: University of Saskatchewan. .
Zhang, D. (2014). Data Transfer and Sharing within Web Service Workflows. Australia, SA: University of Adelaide. .
(2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B.
(2018). . Patent Number: NO2968312T3.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B.
(2018). Methods and compositions. Patent Number: GB201817444D0.
(2018). . Patent Number: NO2699601T3.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2018). Antibody epitope. Patent Number: IL256097A.